ADHD

Alcobra Ltd. News Headlines

$20.54
*  
0.28
1.38%
Get ADHD Alerts
*Delayed - data as of Sep. 23, 2014 13:29 ET  -  Find a broker to begin trading ADHD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ADHD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape
9/18/2014 9:25:00 AM - Zacks.com

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
9/17/2014 7:00:00 PM - Zacks.com

Alcobra To Present At Aegis Healthcare Conference; Webcast At 4:00 PM ET
9/11/2014 3:00:00 PM - RTT News

Steve Brozak: Big-Picture Biotech Stocks Rule The Future
9/5/2014 1:51:00 AM - Seeking Alpha

Why Alcobra (ADHD) Stock Is Declining Today
8/27/2014 9:58:00 AM - TheStreet

Clinical Trial Results To Watch
8/25/2014 9:40:00 AM - Seeking Alpha

Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX - Analyst Blog
8/20/2014 6:21:00 PM - Zacks.com

Alcobra : First Patient Enrolled In Phase IIb Fragile X Study Of MDX
8/19/2014 8:10:00 AM - RTT News

Supernus's SPN-810 Gets Fast Track Status for ADHD - Analyst Blog
8/18/2014 1:30:00 PM - Zacks.com

Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal - Analyst Blog
7/22/2014 11:01:00 AM - Zacks.com

Alcobra Investor Forum;webcast At 8:00 AM ET
7/15/2014 7:01:00 AM - RTT News

ANTH Rekindles Hope For Sollpura, AERI Launches Rockets, Pay Attention To ADHD
7/15/2014 1:24:00 AM - RTT News

Shire Meets AbbVie for Acquisition Deal - Analyst Blog
7/14/2014 2:18:00 PM - Zacks.com

Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape
7/3/2014 9:46:00 AM - Zacks.com

Shire Snubs AbbVie Offer Again, Favorable Ruling for Vyvanse - Analyst Blog
6/26/2014 2:25:00 PM - Zacks.com

Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
6/24/2014 8:35:00 AM - Zacks.com

Shire Rejects AbbVie's Offer, Shares Up - Analyst Blog
6/23/2014 5:31:00 PM - Zacks.com

Shire to Conduct Trials on Vyvanse on FDA's Request - Analyst Blog
6/13/2014 6:25:00 PM - Zacks.com

Alcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% - Tale of the Tape
6/12/2014 9:18:00 AM - Zacks.com

Shire Meets FDA for Lifitegrast - Analyst Blog
5/19/2014 5:30:00 PM - Zacks.com

Alcobra Ltd. Poised To Gain Some Attention In ADHD Market
5/6/2014 11:52:00 AM - Seeking Alpha

Shire Beats on Earnings in Q1 - Analyst Blog
5/2/2014 3:05:01 PM - Zacks.com

Is Actavis (ACT) Poised to Beat Earnings Estimates? - Analyst Blog
4/29/2014 3:16:01 PM - Zacks.com

Venture Capitalist Ran Nussbaum Brings Big Finance To Little Biotechs
4/4/2014 8:31:00 AM - Seeking Alpha

Pipeline Update from Alcobra - Analyst Blog
3/24/2014 12:10:01 PM - Zacks.com